Application no. and date | 17710160.7 (espacenet) (Federated) (European Patent Register), 20170303 | Patent/reg. no. and date | DK/EP 3423082, 20210804 | Publication date | 20190109 | Priority no. and date | EP 16158739, 20160304, EP 16173917, 20160610, EP 16001329, 20160613, US 201715401651, 20170109 | EP pub. no. and date |
EP 3423082 20190109 | Effective date | | Applicant/owner | Novo Nordisk A/S, Novo Allé 1, 2880 Bagsværd, DK | Applicant ref. no. | 160025DK01 | Inventor | KVIST, Kajsa, Novo Allé, 2880 Bagsværd, DK, RASMUSSEN, Søren, Novo Allé, 2880 Bagsværd, DK | Representative | Novo Nordisk A/S, Novo Allé 1, 2880 Bagsværd, DK | Opponent | | IPC Class | A61K 38/26 (2006.01) , A61K 47/02 (2006.01) , A61K 47/10 (2017.01) , A61P 13/12 (2006.01) , A61P 3/10 (2006.01) , A61P 43/00 (2006.01) , A61P 7/12 (2006.01) , A61P 9/00 (2006.01) , A61P 9/04 (2006.01) , A61P 9/10 (2006.01) | Title | LIRAGLUTID VED KARDIOVASKULÆRE TILSTANDE | Int. application no. | EP2017054990 | Int. publication no. | WO2017149112 | Related patent (certificate) | | Status | Rettet DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|